<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="pediatrics" lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher">JOHS</journal-id>
      <journal-id journal-id-type="nlm-ta">Journ of Health Scien</journal-id>
      <journal-title-group>
        <journal-title>Journal of HealthCare Sciences</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Journ of Health Scien</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2231-2196</issn>
      <issn pub-type="opub">0975-5241</issn>
      <publisher>
        <publisher-name>Radiance Research Academy</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">311</article-id>
      <article-id pub-id-type="doi">http://dx.doi.org/10.52533/JOHS.2024.41101</article-id>
      <article-id pub-id-type="doi-url"/>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Pediatrics</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Oral Manifestations and Dental Management of Pediatric Autoimmune Diseases&#13;
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>AlDomyati</surname>
            <given-names>Roaa Mohammad</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alshehri</surname>
            <given-names>Nouf Ghanem</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alahmari</surname>
            <given-names>Amal Saad</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Muslih</surname>
            <given-names>Wejdan Dhafer</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alluhaibi</surname>
            <given-names>Hamza Turki</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alduiji</surname>
            <given-names>Farah Saleh</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alnimasi</surname>
            <given-names>Raya Mubarak</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="ppub">
        <day>4</day>
        <month>11</month>
        <year>2024</year>
      </pub-date>
      <volume>4</volume>
      <issue>11</issue>
      <fpage>547</fpage>
      <lpage>552</lpage>
      <permissions>
        <copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Pediatric autoimmune diseases often present with a range of oral manifestations, including mucosal lesions, xerostomia, and periodontal disease. These symptoms can serve as early indicators of systemic illness, making prompt recognition and management by dental professionals critical. The immunosuppressive therapies commonly used to manage autoimmune diseases, such as corticosteroids and methotrexate, can exacerbate oral health issues, leading to increased susceptibility to infections, delayed wound healing, and complications during routine dental procedures. Preventive care and patient education are essential to mitigate these risks. Regular dental check-ups, professional cleanings, fluoride treatments, and the use of sealants are crucial preventive measures. Additionally, educating patients and caregivers on proper oral hygiene practices and providing dietary advice can help maintain oral health. Interdisciplinary collaboration between dental professionals and other healthcare providers, such as pediatricians and rheumatologists, ensures comprehensive care that addresses both oral and systemic health concerns. This collaboration is particularly important when planning dental procedures that may be affected by the patient__ampersandsign#39;s medication regimen or disease activity. Minimally invasive dental techniques, such as atraumatic restorative treatment and the use of dental lasers, can reduce the need for extensive procedures, thereby minimizing complications and improving patient comfort. The use of biocompatible materials and the avoidance of allergens are also important considerations. By implementing these strategies, dental professionals can significantly improve the oral health and overall well-being of pediatric patients with autoimmune diseases, ensuring their unique needs are met in a holistic manner. Effective dental management of these patients requires a multifaceted approach that includes preventive measures, patient and caregiver education, and interdisciplinary collaboration, ultimately leading to better health outcomes and quality of life for these young patients.&#13;
</p>
      </abstract>
      <kwd-group>
        <kwd>Pediatric autoimmune diseases</kwd>
        <kwd> oral manifestations</kwd>
        <kwd> dental management</kwd>
        <kwd> preventive care</kwd>
        <kwd> interdisciplinary collaboration</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>